SCHEMBL25430982

SCHEMBL25430982

NS(=O)(=O)c1cc(N2NC=CS2)c2cn[nH]c2c1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 1/20 0.34
IDO1 P14902 2/20 0.33
TDO2 P48775 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25432923 0.80
SCHEMBL25436669 0.77 IDO1 (0.33) METAP2IDO1TDO2
SCHEMBL25435644 0.75 PARG (0.31)
SCHEMBL25439477 0.72 IDO1 (0.30) IDO1TDO2
SCHEMBL30621735 0.69 CA1 (0.42) METAP2IDO1TDO2
SCHEMBL30485728 0.65 CYP3A4 (0.47) IDO1TDO2
SCHEMBL5767535 0.65 KDM4E (0.44)
SCHEMBL30485698 0.60 MAPT (0.55) METAP2
SCHEMBL23124425 0.60 MAPT (0.55) METAP2
SCHEMBL6643829 0.59 CA2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154913-A1 INHIBITORS OF PARG ARASE THERAPEUTICS INC. (US) 2023-08-17 WO claimed
EP-4479387-A1 INHIBITORS OF PARG ARase Therapeutics Inc. (US) 2024-12-25 EP disclosed
WO-2023154913-A1 INHIBITORS OF PARG ARASE THERAPEUTICS INC. (US) 2023-08-17 WO disclosed